Investing.com -- OnlyFans CEO Keily Blair stated that artificial intelligence cannot replace human-created content on the platform during her appearance at Bloomberg Tech London on Tuesday.

Investing.com -- Cohere Inc. is planning to go public "soon," according to Bloomberg, citing Chief Executive Officer Aidan Gomez, potentially marking one of the first IPOs from an artificial ...

Investing.com -- Citi upgraded Sunrun and Nextracker to Buy, saying policy clarity in U.S. renewables has reduced uncertainty and created stronger demand visibility ahead of earnings season. The ...

The activist investor also recommended that BARK secure inventory financing against its $98 million in paid-for inventory to free up capital for growth initiatives. Additionally, Shay Capital ...

The notice indicates WhiteOak, a subsidiary of Chinese company Zhejiang Haichang Biotechnology Co Ltd, has filed an Abbreviated New Drug Application (ANDA) with the FDA seeking approval for a generic ...

Investing.com -- Airbnb announced Tuesday that it has introduced new social features for its Experiences platform. The feature is said to allow guests to connect with each other before, during and ...

In a statement, the CEO emphasized that Anthropic’s core principle is that "AI should be a force for human progress, not peril," and expressed agreement with Vice President JD Vance’s recent comments ...

Investing.com -- Tokyo-based artificial intelligence developer Sakana AI is in discussions with U.S. and Japanese investors to secure $100 million in funding at a $2.5 billion valuation, representing ...

Investing.com -- The Hungarian central bank maintained its policy rate at 6.50% on Tuesday, in line with market expectations. The Monetary Council reaffirmed its commitment to achieving the 3% ...

Investing.com -- Spero Therapeutics (NASDAQ:SPRO) stock rose 7% on Tuesday after the company and partner GSK (NYSE:GSK) announced positive Phase 3 trial results for tebipenem HBr, a potential first-in ...

Investing.com -- GATX Corporation (NYSE:GATX) reported third-quarter earnings that fell short of analyst expectations, ...

For the quarter ended September 30, 2025, Balchem posted adjusted earnings per share of $1.35, surpassing the analyst consensus of $1.15 by $0.20. Revenue reached a record $267.6 million, exceeding ...